• Enzyme-targeted drug discovery patterns emphasize inhibitors and substrate interactions, illustrated by trypsin inhibitors, leucine aminopeptidase activity assays, and competitive inhibition frameworks across multiple organisms [1], [2], [3], [6], [11], [12], [17].

• Pharmacokinetic design dominated early drug development, linking absorption and distribution to metabolism and microsomal induction; phenobarbital effects and hepatic enzyme induction were central to understanding drug action [4], [8], [9], [18], [19], [20].

• Molecular and biochemical foundations of drug action through mapping of enzyme activity, substrate specificity, and molecular targets guiding therapeutic strategies [1], [6], [7], [11], [16], [17].

• Clinical pharmacology and translational medicine contexts frame drug-target interactions in penicillins, serotonin pharmacology, and neuropharmacology [10], [13], [15].